((hept-6-en-1-yloxy)methyl)benzene | 898544-02-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ((hept-6-en-1-yloxy)methyl)benzene
• 英文别名: ((hept-6-enyloxy)methyl)benzene；hept-6-enoxymethylbenzene
• CAS: 898544-02-0
• 化学式: C₁₄H₂₀O
• 分子量: 204.312
• InChiKey: JCGGDUWEIJOEMO-UHFFFAOYSA-N

物化性质

• 沸点：
  284.5±19.0 °C(Predicted)
• 密度：
  0.917±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  15
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  ((hept-6-en-1-yloxy)methyl)benzene 在 Grubbs' vinylidene catalyst 三苯基膦 作用下， 以 二氯甲烷 为溶剂， 生成 (2Z,4E)-ethyl 10-(benzyloxy)-4-methyldeca-2,4-dienoate
  参考文献：
  名称：

  Ruthenium-Catalyzed Tandem Cross-Metathesis/Wittig Olefination:  Generation of Conjugated Dienoic Esters from Terminal Olefins

  摘要：

  In the presence of ruthenium-based olefin metathesis catalysts and triphenylphosphine, alpha,beta-unsaturated aldehydes can be olefinated with diazoacetates. This ruthenium-catalyzed transformation has been employed in tandem with olefin cross-metathesis to convert terminal olefins into 1,3-dienoic esters in a single operation.

  DOI：

  10.1021/ol070445t
• 作为产物：
  描述：

  7-溴-1-庚烯 、 苯甲醇 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 12.75h， 以87%的产率得到((hept-6-en-1-yloxy)methyl)benzene
  参考文献：
  名称：

  Development of Amidine-Based Sphingosine Kinase 1 Nanomolar Inhibitors and Reduction of Sphingosine 1-Phosphate in Human Leukemia Cells

  摘要：

  Sphingosine 1-phosphate (S1P) is a bioactive lipid that has been identified as an accelerant of cancer progression. The sphingosine kinases (SphKs) are the sole producers of S1P, and thus, SphK inhibitors may prove effective in cancer mitigation and chemosensitization. Of the two SphKs, SphK1 overexpression has been observed in a myriad of cancer cell lines and tissues and has been recognized as the presumptive target over that of the poorly characterized SphK2. Herein, we present the design and synthesis of amidine-based nanomolar SphK1 subtype-selective inhibitors. A homology model of SphK1, trained with this library of amidine inhibitors, was then used to predict the activity of additional, more potent, inhibitors. Lastly, select amidine inhibitors were validated in human leukemia U937 cells, where they significantly reduced endogenous S1P levels at nanomolar concentrations.

  DOI：

  10.1021/jm2001053

文献信息

• IMIDAMIDE SPHINGOSINE KINASE INHIBITORS
  申请人：Lynch Kevin R.

  公开号：US20120214858A1

  公开（公告）日：2012-08-23

  Imidamide (amidine) analogs that can inhibit the activity of sphingosine kinase 1 and sphingosine kinase 2 (SphK1 & SphK2) are provided. The compounds can prevent angiogenesis in tumors.

  提供可以抑制神经酰胺激酶1和神经酰胺激酶2（SphK1和SphK2）活性的Imidamide（胺基）类似物。这些化合物可以预防肿瘤中的血管生成。
• Ring-Conformer Effects of the Cyclopropyl Group: First Use of trans-(2R,3R)-Cyclopropanecarbaldehydes as Electrophiles in Diastereoselective Baylis-Hillman Reaction
  作者：Palakodety Radha Krishna、S. Kishore、P. Srinivas Reddy

  DOI：10.1055/s-0029-1218019

  日期：2009.10

  trans-(2R,3R)-Cyclopropanecarbaldehydes are used as novel electrophiles in the Baylis-Hillman reaction to afford adducts in good yields (75-85%) and diastereoselectivities (60-90%).

  trans-(2R,3R)-环丙烷碳醛作为新型亲电试剂用于Baylis-Hillman反应，能够获得良好的产物收率（75-85%）和非对映选择性（60-90%）。
• Preparation of Aliphatic Ketones through a Ruthenium-Catalyzed Tandem Cross-Metathesis/Allylic Alcohol Isomerization
  作者：David Finnegan、Benjamin A. Seigal、Marc L. Snapper

  DOI：10.1021/ol060918g

  日期：2006.6.1

  shown to be effective catalysts for cross-metatheses of allylic alcohols with cyclic and acyclic olefins, as well as isomerization of the resulting allylic alcohols to alkyl ketones. The net result of this new tandem methodology is a single-flask process that provides highly functionalized, ketone-containing products from simple allylic alcohol precursors. [reaction: see text]

  事实证明，Grubbs的第二代和Hoveyda-Grubbs的钌烷基亚烷基是有效的催化剂，用于烯丙醇与环和无环烯烃的间-烷间转移，以及将所得的烯丙醇异构化为烷基酮。这种新的串联方法的最终结果是一个单瓶工艺，该工艺可以从简单的烯丙醇前体中提供高度功能化的含酮产品。[反应：看文字]
• Imidamide sphingosine kinase inhibitors
  申请人：Lynch Kevin R.

  公开号：US09421177B2

  公开（公告）日：2016-08-23

  Imidamide (amidine) analogs that can inhibit the activity of sphingosine kinase 1 and sphingosine kinase 2 (SphK1 & SphK2) are provided. The compounds can prevent angiogenesis in tumors.

  提供了能够抑制鞘氨醇激酶1和鞘氨醇激酶2(SphK1 & SphK2)活性的imidamide（酰胺）类似物。这些化合物可以防止肿瘤的血管生成。
• US9421177B2
  申请人：——

  公开号：US9421177B2

  公开（公告）日：2016-08-23